(3S,6S,9S,12S)-1-((S)-1-((2S,5S,8S,11S,14S)-2-((1H-imidazol-5-yl)methyl)-14,18-diamino-8-benzyl-11-(2-carboxyethyl)-5-isobutyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecane)pyrrolidin-2-yl)-6-(4-aminobutyl)-12-((S)-1-((S)-2-((S)-1-carboxy-4-guanidinobutylcarbamoyl)pyrrolidin-1-yl)-4-methyl-1-oxopentan-2-ylcarbamoyl)-3-(hydroxymethyl)-9-isopropyl-1,4,7,10-tetraoxo-2,5,8,11-tetraazatetradecan-14-oic acid (Compound)
Analyze
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (3S,6S,9S,12S)-1-((S)-1-((2S,5S,8S,11S,14S)-2-((1H-imidazol-5-yl)methyl)-14,18-diamino-8-benzyl-11-(2-carboxyethyl)-5-isobutyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecane)pyrrolidin-2-yl)-6-(4-aminobutyl)-12-((S)-1-((S)-2-((S)-1-carboxy-4-guanidinobutylcarbamoyl)pyrrolidin-1-yl)-4-methyl-1-oxopentan-2-ylcarbamoyl)-3-(hydroxymethyl)-9-isopropyl-1,4,7,10-tetraoxo-2,5,8,11-tetraazatetradecan-14-oic acid's neighborhood in the knowledge graph.
The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for (3S,6S,9S,12S)-1-((S)-1-((2S,5S,8S,11S,14S)-2-((1H-imidazol-5-yl)methyl)-14,18-diamino-8-benzyl-11-(2-carboxyethyl)-5-isobutyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecane)pyrrolidin-2-yl)-6-(4-aminobutyl)-12-((S)-1-((S)-2-((S)-1-carboxy-4-guanidinobutylcarbamoyl)pyrrolidin-1-yl)-4-methyl-1-oxopentan-2-ylcarbamoyl)-3-(hydroxymethyl)-9-isopropyl-1,4,7,10-tetraoxo-2,5,8,11-tetraazatetradecan-14-oic acid.
The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with (3S,6S,9S,12S)-1-((S)-1-((2S,5S,8S,11S,14S)-2-((1H-imidazol-5-yl)methyl)-14,18-diamino-8-benzyl-11-(2-carboxyethyl)-5-isobutyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecane)pyrrolidin-2-yl)-6-(4-aminobutyl)-12-((S)-1-((S)-2-((S)-1-carboxy-4-guanidinobutylcarbamoyl)pyrrolidin-1-yl)-4-methyl-1-oxopentan-2-ylcarbamoyl)-3-(hydroxymethyl)-9-isopropyl-1,4,7,10-tetraoxo-2,5,8,11-tetraazatetradecan-14-oic acid.
Results found
Linked to
(3S,6S,9S,12S)-1-((S)-1-((2S,5S,8S,11S,14S)-2-((1H-imidazol-5-yl)methyl)-14,18-diamino-8-benzyl-11-(2-carboxyethyl)-5-isobutyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecane)pyrrolidin-2-yl)-6-(4-aminobutyl)-12-((S)-1-((S)-2-((S)-1-carboxy-4-guanidinobutylcarbamoyl)pyrrolidin-1-yl)-4-methyl-1-oxopentan-2-ylcarbamoyl)-3-(hydroxymethyl)-9-isopropyl-1,4,7,10-tetraoxo-2,5,8,11-tetraazatetradecan-14-oic acid bioactivity Transient receptor potential cation channel subfamily V member 6
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG